ERCC2 and non-small cell lung carcinoma: Another meta‐analysis in 2011 including 17 studies also found that neither ERCC1 (rs3212986 and rs11615) nor ERCC2 (rs13181) was significantly associated with response and progression‐free survival in NSCLC patients 33.